VITAMIN D MICROEMULSIONS AND THEIR APPLICATIONS Russian patent published in 2024 - IPC A61K9/107 A61K31/593 A61K47/24 A61P27/02 

Abstract RU 2812079 C2

FIELD: pharmaceutical industry; ophthalmic pharmaceutical composition and its applications.

SUBSTANCE: ophthalmic topical pharmaceutical composition containing a phospholipid nanoemulsion with vitamin D in the range from 0.02 to 1.4 wt./vol.% and phospholipids in the range from 0.1 to 5 wt./vol.%, where the emulsified particles have the size particles ranging from 100 to 300 nanometers in diameter, and phospholipids and vitamin D are in a ratio of at least 3:1. Use of said pharmaceutical composition for storing or maintaining isolated corneas; use of an ophthalmic pharmaceutical composition for the manufacture of a topical medicinal product for reducing the absorption of light in the wavelength range of 220-520 nm in the eyes; use of an ophthalmic pharmaceutical composition for manufacturing of a topical medicament for improved delivery of vitamin D to the eyes; use of an ophthalmic pharmaceutical composition for manufacturing of a topical medicinal product for treatment of an eye disease or condition.

EFFECT: use of the group of inventions provides local therapy that does not cause irritation, has increased duration, sufficient to improve the diffusion of lipophilic agents into the epithelial layers of the cornea and into the posterior segment of the eye.

23 cl, 12 dwg, 9 tbl

Similar patents RU2812079C2

Title Year Author Number
OPHTHALMOLOGICAL COMPOSITIONS 2017
  • Delgado Ganan, Isabel
  • Marchan Sancho, Sandra
  • Iskierdo Torres, Fransiska
RU2756758C2
ESTERS FOR TREATMENT OF OPHTHALMOLOGICAL INFLAMMATORY DISEASES 2012
  • Gallua-Berno Annabell
  • Molok Ml. Frenk F.
  • Devis Kerri L.
  • Lorents Keti Osborn
  • Yang Dzhejms K.
  • Kanavan Kristi L.
  • Lu Fan
RU2640506C9
ESTERS FOR TREATING OPHTHALMIC INFLAMMATORY DISEASES 2012
  • Gallois-Bernos Annabelle
  • Molock Jr. Frank F.
  • Davis Carrie L.
  • Lorenz Kathy Osborn
  • Young James K.
  • Canavan Kristy L.
  • Lu Fang
RU2707961C2
BIS-NAPHTHAZARIN BASED AGENT AND METHOD FOR PRODUCTION THEREOF 2016
  • Urakova Irina Nikolaevna
  • Demchenko Dmitrij Valentinovich
  • Pozharitskaya Olga Nikolaevna
  • Shikov Aleksandr Nikolaevich
  • Makarova Marina Nikolaevna
  • Makarov Valerij Gennadevich
  • Fomichev Yurij Sergeevich
RU2669374C2
LIPID-BASED OPHTHALMIC EMULSION 2019
  • Ketelson, Howard Allen
  • Davis, James W.
  • Rangarajan, Rekha
RU2793333C2
ESTERS FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISEASES 2012
  • Gallois Annabelle
RU2747953C2
THERAPEUTIC RECOVERY AND ENHANCEMENT OF OCULAR SURFACE WETTING 2009
  • Sallivan Bendzhamin
  • Shmidt Tannin A.
  • Sallivan Dehvid A.
RU2510274C2
COMPOUND ETHERS FOR TREATMENT OF OPHTHALMOLOGICAL INFLAMMATORY DISEASES 2012
  • Gallua Annabell
RU2673230C1
ESTERS FOR OPHTHALMOLOGICAL INFLAMMATORY DISEASES TREATMENT 2012
  • Gallua Annabell
RU2627438C2
EYE DROPS BASED ON COMPOSITION OF PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND METHYLETHYL PYRIDONOL AND TAURINE CONTAINING COMPOSITION OF GROUP B VITAMINS 2013
  • Kedik Stanislav Anatol'Evich
  • Panov Aleksej Valer'Evich
  • Suslov Vasilij Viktorovich
  • Kochkina Julija Vjacheslavovna
  • Zatonskij Georgij Valer'Evich
RU2533276C1

RU 2 812 079 C2

Authors

Ezra, Rafael

Manor, Joni

Dates

2024-01-22Published

2019-12-06Filed